AC
Armistice Capital’s Immunocore IMCR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.3M | Sell |
678,000
-300,000
| -31% | -$9.41M | 0.37% | 39 |
|
2025
Q1 | $29M | Sell |
978,000
-222,000
| -19% | -$6.59M | 0.43% | 42 |
|
2024
Q4 | $35.4M | Sell |
1,200,000
-64,000
| -5% | -$1.89M | 0.48% | 37 |
|
2024
Q3 | $39.3M | Buy |
1,264,000
+288,000
| +30% | +$8.97M | 0.63% | 29 |
|
2024
Q2 | $33.1M | Buy |
976,000
+812,000
| +495% | +$27.5M | 0.42% | 39 |
|
2024
Q1 | $10.7M | Sell |
164,000
-148,000
| -47% | -$9.62M | 0.14% | 95 |
|
2023
Q4 | $21.3M | Sell |
312,000
-88,000
| -22% | -$6.01M | 0.29% | 55 |
|
2023
Q3 | $20.8M | Sell |
400,000
-28,000
| -7% | -$1.45M | 0.32% | 51 |
|
2023
Q2 | $25.7M | Buy |
428,000
+50,000
| +13% | +$3M | 0.37% | 49 |
|
2023
Q1 | $18.7M | Buy |
378,000
+42,000
| +13% | +$2.08M | 0.27% | 65 |
|
2022
Q4 | $19.2M | Buy |
336,000
+20,000
| +6% | +$1.14M | 0.33% | 56 |
|
2022
Q3 | $14.8M | Buy |
316,000
+48,000
| +18% | +$2.25M | 0.26% | 64 |
|
2022
Q2 | $10K | Buy |
268,000
+88,000
| +49% | +$3.28K | 0.17% | 79 |
|
2022
Q1 | $5.38M | Buy |
+180,000
| New | +$5.38M | 0.1% | 82 |
|